Glenmark Pharma reported Rs 340 crore net profit in Q2FY25 led by robust sales growth in India and Europe. The drugmaker reported a net loss of Rs 180 crore in the corresponding quarter of the previous year.
Upbeat earnings bolster case for India stocks as Asia wavers
Indian equities are outperforming Asian peers, supported by stronger-than-expected corporate earnings, improving valuations and renewed foreign investor inflows. September-quarter profits rose 20% among major companies,